Overview

Pregabalin for Treatment of Patients With Postherpetic Neuralgia (PHN)

Status:
Completed
Trial end date:
2014-01-01
Target enrollment:
Participant gender:
Summary
To prove pregabalin is effective in relieving pain compared with placebo in subjects with postherpetic neuralgia (PHN).
Phase:
Phase 4
Details
Lead Sponsor:
Pfizer
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Treatments:
Pregabalin